Modelling endogenous insulin concentration in type 2 diabetes during closed loop insulin delivery
Wilinska, Malgorzata E.
Biomedical Engineering Online
MetadataShow full item record
Ruan, Y., Thabit, H., Wilinska, M. E., & Hovorka, R. (2015). Modelling endogenous insulin concentration in type 2 diabetes during closed loop insulin delivery. Biomedical Engineering Online, 14 (19)https://doi.org/10.1186/s12938-015-0009-5
This is the final published version. It first appeared at http://www.biomedical-engineering-online.com/content/14/1/19.
Background: Closed-loop insulin delivery is an emerging treatment for type 1 diabetes (T1D) evaluated clinically and using computer simulations during pre-clinical testing. Efforts to make closed-loop systems available to people with type 2 diabetes (T2D) calls for the development of a new type of simulators to accommodate differences between T1D and T2D. Presented here is the development of a model of posthepatic endogenous insulin concentration, a component omitted in T1D simulators but key for simulating T2D physiology. Methods: We evaluated six competing models to describe the time course of endogenous insulin concentration as a function of the plasma glucose concentration and time. The models were fitted to data collected in insulin-naive subjects with T2D who underwent two 24-h visits and were treated, in a random order, by either closed-loop insulin delivery or glucose-lowering oral agents. The model parameters were estimated using a Bayesian approach, as implemented in the WinBUGS software. Model selection criteria were used to identify the best model describing our clinical data. Results: The selected model successfully described endogenous insulin concentration over 24 h in both study periods and provided plausible parameter estimates. Model-derived results were in concordance with a clinical finding which revealed increased posthepatic endogenous insulin concentration during the control study period (P < 0.05). The modelling results indicated that the excess amount of insulin can be attributed to the glucose-independent effect as the glucose-dependent effect was similar between visits (P > 0.05). Conclusions: A model to describe endogenous insulin concentration in T2D including components of posthepatic glucose-dependent and glucose-independent insulin secretion was identified and validated. The model is suitable to be incorporated in a simulation environment for evaluating closed-loop insulin delivery in T2D.
Posthepatic endogenous insulin concentration, Closed-loop insulin delivery, Simulation, Modelling, Insulin secretion, Type 2 diabetes
This work was funded in part by a National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre Grant, Diabetes UK (BDA07/0003549), and Wellcome Strategic Award (100574/Z/12/Z). The research was conducted with support from Addenbrooke’s Clinical Research Facility (Cambridge, UK). We gratefully acknowledge laboratory support from Angie Watts (University of Cambridge, Cambridge UK), Dr Stephen Luzio and Mr Gareth Dunseath (University of Swansea, Swansea, UK), and Dr Keith Burling (University of Cambridge, UK).
External DOI: https://doi.org/10.1186/s12938-015-0009-5
This record's URL: https://www.repository.cam.ac.uk/handle/1810/248007
Attribution 2.0 UK: England & Wales
Licence URL: http://creativecommons.org/licenses/by/2.0/uk/
Recommended or similar items
The following licence files are associated with this item: